BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allanore Y, Bozzi S, Terlinden A, Huscher D, Amand C, Soubrane C, Siegert E, Czirják L, Carreira PE, Hachulla E, Zanatta E, Li M, Airò P, Mendoza FA, Rosato E, Distler O; EUSTAR Collaborators. Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database. Arthritis Res Ther 2020;22:257. [PMID: 33115544 DOI: 10.1186/s13075-020-02329-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Herrick AL, Assassi S, Denton CP. Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need. Nat Rev Rheumatol 2022. [PMID: 35292731 DOI: 10.1038/s41584-022-00765-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lazzaroni MG, Piantoni S, Angeli F, Bertocchi S, Franceschini F, Airò P. A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis. Clin Rev Allergy Immunol 2022. [PMID: 35254622 DOI: 10.1007/s12016-022-08929-x] [Reference Citation Analysis]
3 Guaracha-Basáñez GA, Contreras-Yáñez I, Hernández-Molina G, Estrada-González VA, Pacheco-Santiago LD, Valverde-Hernández SS, Galindo-Donaire JR, Peláez-Ballestas I, Pascual-Ramos V. Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path. PLoS One 2022;17:e0262756. [PMID: 35041692 DOI: 10.1371/journal.pone.0262756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hatefi M, Nouri L. Association Between Pain with Disability in the Elderly with Dementia. Arch Neurosci 2021;In Press. [DOI: 10.5812/ans.119913] [Reference Citation Analysis]
5 Becker MO, Dobrota R, Garaiman A, Debelak R, Fligelstone K, Tyrrell Kennedy A, Roennow A, Allanore Y, Carreira PE, Czirják L, Denton CP, Hesselstrand R, Sandqvist G, Kowal-Bielecka O, Bruni C, Matucci-Cerinic M, Mihai C, Gheorghiu AM, Mueller-Ladner U, Sexton J, Kvien TK, Heiberg T, Distler O. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire. Ann Rheum Dis 2021:annrheumdis-2021-220702. [PMID: 34824049 DOI: 10.1136/annrheumdis-2021-220702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kaymaz S, Karasu U, Alkan H, Cobankara V. Turkish version of modified Hand Mobility in Scleroderma test: A translation and validation study. Int J Rheum Dis 2021;24:1040-6. [PMID: 34159735 DOI: 10.1111/1756-185X.14162] [Reference Citation Analysis]
7 Allanore Y, Constans J, Godard D, de Pouvourville G, Bouee S, Jeanbat V, Teissier C, Le Lay K, Chollet J, Hachulla E. Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in France. Journal of Scleroderma and Related Disorders 2022;7:49-56. [DOI: 10.1177/23971983211013979] [Reference Citation Analysis]